GAMMA Investing LLC

Position in EXEL — Exelixis, Inc.

CIK 2010235 FOSTER CITY, CA

Position in EXEL

as of Mar 31, 2026 · filed Apr 6, 2026 Compact

Position Value

$410,971

+$10,409 QoQ

Shares Held

9,582

+4.8% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GAMMA Investing LLC holds $15,891,706 across 254 Biotechnology names. EXEL ranks #6 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,592	$2,943,591
2	REGN	Regeneron Pharmaceuticals, Inc.	2,507	$1,937,008
3	MRNA	Moderna, Inc.	15,297	$777,087
4	INCY	Incyte Corp	7,261	$683,405
5	TECH	BIO-TECHNE Corp	10,065	$525,996
6	EXEL	Exelixis, Inc. This page	9,582	$410,971
7	ROIV	Roivant Sciences Ltd.	12,465	$345,280
8	ALNY	Alnylam Pharmaceuticals, Inc.	994	$328,884

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$410,971	9,582	+4.8%	Shares	Defined	2026-04-06
2025-12-31	$400,562	9,139	+23.0%	Shares	Defined	2026-01-05
2025-09-30	$306,817	7,429	-11.0%	Shares	Defined	2025-10-02
2025-06-30	$367,891	8,346	+52.9%	Shares	Defined	2025-07-14
2025-03-31	$201,472	5,457	+32.2%	Shares	Defined	2025-04-15
2024-12-31	$137,495	4,129	+37.2%	Shares	Defined	2025-01-03
2024-09-30	$78,109	3,010	+50.0%	Shares	Defined	2024-10-07
2024-06-30	$45,074	2,006	+107.9%	Shares	Defined	2024-07-02
2024-03-31	$22,899	965	-15.4%	Shares	Defined	2024-04-05
2023-12-31	$27,348	1,140	—	Shares	Defined	2024-02-01
No filing history on record for this holder in this stock.